Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neovascularization, Pathologic × Zoledronic Acid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 53 Prostatic Neoplasms 41 Neoplasm Metastasis 25 Multiple Myeloma 25 Pain 13 Osteoporosis 13 Carcinoma, Non-Small-Cell Lung 10 Neoplasms 9 Osteosarcoma 7 Lung Neoplasms 6 Carcinoma, Renal Cell 6 Neuroblastoma 5 Neoplasms, Plasma Cell 5 Humoral Hypercalcemia Of Malignancy 5 Fractures, Bone 4 Bone Diseases, Metabolic 4 Sarcoma, Ewing 3 Sarcoma 3 Lymphoma 3 Kidney Neoplasms 3 Bone Neoplasms 3 Bone Diseases 3 Uterine Cervical Neoplasms 2 Triple Negative Breast Neoplasms 2 Spinal Cord Compression 2 Small Cell Lung Carcinoma 2 Rhabdomyosarcoma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Pleural Effusion, Malignant 2 Ovarian Neoplasms 2

Interventions

S 3304 2 Zoledronic Acid 1 Rubidium-82 1 Neoadjuvant Therapy 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01367288 2019-05-28

NEOZOL

Hospices Civils de Lyon

Phase 2 Completed

Breast Neoplasms, Neovascularization, Pathologic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡